TABLE 01. RISK FOR SUBARACHNOID HEMORRHAGE BASED ON SMOKING LEVEL
TABLE 02. PATIENTS TREATED, BY DRUG CLASS, 2015-2017
TABLE 03. GLOBAL ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 04. OPIOID ANALGESICS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 05. CALCIUM CHANNEL BLOCKERS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 06. ANTICONVULSANTS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 07. STOOL SOFTENERS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 08. OSMOTIC AGENTS/DIURETICS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 09. OTHER DRUGS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 10. ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY REGION, 2016-2023 ($THOUSAND)
TABLE 11. NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY COUNTRY, 2016-2023 ($THOUSAND)
TABLE 12. U.S. ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 13. CANADA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 14. MEXICO ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 15. NORTH AMERICA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 16. EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY COUNTRY, 2016-2023 ($THOUSAND)
TABLE 17. GERMANY ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 18. FRANCE ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 19. UK ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 20. ITALY ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 21. SPAIN ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 22. REST OF EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 23. EUROPE ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 24. ASIA-PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY COUNTRY, 2016-2023 ($THOUSAND)
TABLE 25. JAPAN ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 26. CHINA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 27. AUSTRALIA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 28. INDIA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 29. SOUTH KOREA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 30. REST OF ASIA-PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 31. ASIA-PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 32. ASIA-PACIFIC ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY COUNTRY, 2016-2023 ($THOUSAND)
TABLE 33. BRAZIL ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 34. SAUDI ARABIA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 35. SOUTH AFRICA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 36. REST OF LAMEA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 37. LAMEA ANEURYSMAL SUBARACHNOID HEMORRHAGE DRUGS MARKET, BY DRUG CLASS, 2016-2023 ($THOUSAND)
TABLE 38. ARBOR: COMPANY SNAPSHOT
TABLE 39. ARBOR: PRODUCT SEGMENTS
TABLE 40. ARBOR: PRODUCT PORTFOLIO
TABLE 41. EDGE THERAPEUTICS: COMPANY SNAPSHOT
TABLE 42. EDGE THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 43. J&J: COMPANY SNAPSHOT
TABLE 44. J&J: OPERATING SEGMENTS
TABLE 45. J&J: PRODUCT PORTFOLIO
TABLE 46. MYLAN: COMPANY SNAPSHOT
TABLE 47. MYLAN: OPERATING SEGMENTS
TABLE 48. MYLAN: PRODUCT PORTFOLIO
TABLE 49. OREXO: COMPANY SNAPSHOT
TABLE 50. OREXO: PRODUCT PORTFOLIO
TABLE 51. PFIZER: COMPANY SNAPSHOT
TABLE 52. PFIZER: OPERATING SEGMENTS
TABLE 53. PFIZER: PRODUCT PORTFOLIO
TABLE 54. PURDUE PHARMA: COMPANY SNAPSHOT
TABLE 55. PURDUE PHARMA: PRODUCT PORTFOLIO
TABLE 56. PHARMAXIS: COMPANY SNAPSHOT
TABLE 57. PHARMAXIS: OPERATING SEGMENTS
TABLE 58. PHARMAXIS: PRODUCT PORTFOLIO
TABLE 59. SUN PHARMA: COMPANY SNAPSHOT
TABLE 60. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 61. TEVA: COMPANY SNAPSHOT
TABLE 62. TEVA: OPERATING SEGMENTS
TABLE 63. TEVA: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2016
FIGURE 04. IMPACT ANALYSES
FIGURE 05. COMPARATIVE ANALYSIS OF OPIOID ANALGESICS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 06. COMPARATIVE ANALYSIS OF CALCIUM CHANNEL BLOCKERS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 07. COMPARATIVE ANALYSIS OF ANTICONVULSANTS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 08. COMPARATIVE ANALYSIS OF STOOL SOFTENERS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 09. COMPARATIVE ANALYSIS OF OSMOTIC AGENTS/DIURETICS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 10. COMPARATIVE ANALYSIS OF OTHER DRUGS MARKET REVENUE, BY COUNTRY, 2016 & 2023(%)
FIGURE 11. J&J: NET SALES, 2015-2017 ($MILLION)
FIGURE 12. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 13. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 14. MYLAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 15. MYLAN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 16. OREXO: NET SALES, 2015-2017 ($MILLION)
FIGURE 17. OREXO: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 18. OREXO: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 19. PFIZER: NET SALES, 2015-2017 ($MILLION)
FIGURE 20. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 21. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 22. PHARMAXIS: NET SALES, 2015-2017 ($MILLION)
FIGURE 23. PHARMAXIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 24. SUN PHARMA: NET SALES, 2015-2017 ($MILLION)
FIGURE 25. SUN PHARMA: REVENUE SHARE BY BUSINESS UNITS, 2017 (%)
FIGURE 26. SUN PHARMA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. TEVA: NET SALES, 2015-2017 ($MILLION)
FIGURE 28. TEVA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. TEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)